Spots Global Cancer Trial Database for paclitaxel poliglumex
Every month we try and update this database with for paclitaxel poliglumex cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC) | NCT00487669 | Advanced Non-sm... | paclitaxel poli... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer | NCT00352690 | Carcinoma, Non-... | Paclitaxel poli... Carboplatin External beam r... | 18 Years - | Washington University School of Medicine | |
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | NCT00551733 | Lung Cancer | carboplatin paclitaxel paclitaxel poli... | 18 Years - 120 Years | CTI BioPharma | |
Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer | NCT00054184 | Lung Cancer | docetaxel paclitaxel poli... | 18 Years - 120 Years | CTI BioPharma | |
Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer | NCT00108745 | Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Ovarian Brenner... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Seromuc... Ovarian Serous ... Ovarian Transit... Ovarian Undiffe... Primary Periton... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... | Clinical Observ... Laboratory Biom... Paclitaxel Paclitaxel Poli... Quality-of-Life... | - | GOG Foundation | |
Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer | NCT00459810 | Prostate Cancer | transdermal est... paclitaxel poli... | 18 Years - 120 Years | OHSU Knight Cancer Institute | |
A Pilot Study of PPX in Women With Metastatic Colorectal Cancer | NCT00598247 | Advanced Colore... | Paclitaxel Poli... | 18 Years - | University of Southern California | |
Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | NCT00054197 | Lung Cancer | gemcitabine hyd... paclitaxel poli... vinorelbine tar... | 18 Years - 120 Years | CTI BioPharma | |
CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer | NCT00045682 | Primary Periton... Recurrent Ovari... | Paclitaxel Poli... | 18 Years - | GOG Foundation | |
Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | NCT00054210 | Lung Cancer | carboplatin paclitaxel paclitaxel poli... | 18 Years - 120 Years | CTI BioPharma | |
Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer | NCT00060359 | Fallopian Tube ... Malignant Ovari... Ovarian Brenner... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Serous ... Primary Periton... Stage III Ovari... Stage IV Ovaria... Undifferentiate... | Carboplatin Paclitaxel Poli... Pharmacological... | 18 Years - | GOG Foundation | |
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | NCT00551733 | Lung Cancer | carboplatin paclitaxel paclitaxel poli... | 18 Years - 120 Years | CTI BioPharma | |
A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. | NCT00269828 | NSCLC | paclitaxel paclitaxel poli... | 18 Years - | CTI BioPharma | |
A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer | NCT00660218 | Carcinoma, Squa... | paclitaxel poli... cetuximab radiation thera... | 18 Years - | State University of New York - Upstate Medical University | |
A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer | NCT00660218 | Carcinoma, Squa... | paclitaxel poli... cetuximab radiation thera... | 18 Years - | State University of New York - Upstate Medical University | |
A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer | NCT00352690 | Carcinoma, Non-... | Paclitaxel poli... Carboplatin External beam r... | 18 Years - | Washington University School of Medicine |